Investigation of occult hepatitis B infection in blood donors in Panyu District, Guangzhou
Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 10
Abstract
Objective To investigate the status of occult hepatitis B virus infection (OBI) among blood donors in Panyu District of Guangzhou, so as to provide reference for blood transfusion safety. Methods From January 1, 2021 to July 31, 2023, 60 872 blood donors in Panyu District with HBsAg-/HBV DNA+ were screened as OBI subjects. The age, gender and frequency of blood donation of OBI donors were statistically analyzed. HBV DNA viral load was detected and hepatitis B five-panel test was performed. Results The HBsAg-/HBV DNA+positive rate of blood donors in Panyu District was 0.08% (50/60 872). The OBI positive rate of male blood donors was higher than that of female blood donors, with no statistically significant difference(P>0.05). The OBI positive rate of blood donors increased with age, with statistically significant difference(P<0.05). The OBI positive rate of first-time blood donors was higher than that of repeat blood donors, with statistically significant difference(P<0.05). Of the 50 HBsAg-/HBV DNA+ donors, 42 had a follow-up test, among which 14 had no HBV DNA detected. The mean value of the initial screening resolution CT was 37.77. In hepatitis B five-panel test, single HBsAb+ accounted for the highest proportion as 50% (7/14). HBV DNA viral load was detected in 28 cases, and viral load <10 IU/mL accounted for 50%(14/28) and that <200 IU/mL accounted for 96% (27/28). The mean value of initial screening resolution CT was 34.55, mainly HBeAb+/HBcAb+ in hepatitis B five-panel test, accounting for 32.14% (9/28). After multiple follow-up of 24 blood donors, 37.5% (9/24) were detected with viral load, 33.33% (8/24) were detected with no viral load, and 29.17% (7/24) had both negative and positive results. The hepatitis B five-panel test outcome of 29.17% (7/24) donors showed a turnover, while 70.83% (17/24) did not. Conclusion The OBI positive rate is lower in young repeat blood donors. Since OBI is the result of a variety of complex mechanisms, and the existing serological NAT cannot detect all OBI donors, strict pre-donation consultation and screening of previous HBV DNA+ donors are very important for blood safety. It is recommended that patients with weakened immunity, such as organ transplantation, tumor chemoradiotherapy, or the use of immunosuppressive drugs, use virus inactivated blood products.
Authors and Affiliations
Pingping CHEN, Wenli LAN, Feifang HONG, Weiwen MA
Keywords
Related Articles
- EP ID EP749838
- DOI 10.13303/j.cjbt.issn.1004-549x.2024.10.009
- Views 73
- Downloads 0
Distribution and molecular basis of A2 subtype in Guangzhou blood donors
Objective To investigate the distribution and molecular basis of A2 subtype among blood donors in Guangzhou. Methods Whole blood samples of 793 group A blood donors in Guangzhou Blood Center were randomly collected. A2 s...
Centralized blood nucleic acid test data in Tibet: a retrospective analysis
Objective To retrospectively analyze the serological and nucleic acid testing(NAT) data of voluntary blood donors from six blood banks in Tibet, in order to explore the positive impact of NAT on reducing the risk of infe...
Screening of hepatitis D virus in blood donors in Dalian
Objective To investigate the prevalence of hepatitis D virus in Dalian blood donors. Methods The samples reactive to HBV in blood screening were selected with the following confirmed results: 1)HBsAg+ &HBV DNA+ ; 2)HBsAg...
Development of the method for determinating ADCC biological activity of IVIG
Objective To establish a method for determinating the antigen-dependent cell-mediated cytotoxicity (ADCC) of human immunoglobulin (pH4)for intravenous injection (IVIG) on luciferase reporter gene-modified cell assay. Met...
Perioperative blood management of a patient with coagulation factor Ⅴ deficiency and literature review
Objective To explore the perioperative blood management in patients with pancreatic pseudocyst combiend with coagulation factor Ⅴ(FⅤ) deficiency. Methods Preoperative: In order to determine the effect of cryoprecipitated...